Insulet expands diabetes innovation with automated insulin delivery system launch in the Middle East.

{
  "signal_id": "b51f2a22-d585-4ce8-8b35-6fab70c77070",
  "signal_type": "news",
  "signal_subtype": "expands_offices_to",
  "detected_at": "2026-03-25T00:00:00+00:00",
  "company": {
    "name": "Insulet",
    "domain": "insulet.com"
  },
  "data": {
    "url": "https://www.precedenceresearch.com/news/insulet-automated-insulin-system-middle-east",
    "title": "Insulet expands diabetes innovation with automated insulin delivery system launch in the Middle East.",
    "excerpt": "Insulet expands diabetes innovation with automated insulin delivery system launch in the Middle East.\n\nPublished: 25 Mar 2026\n\nInsulet Corporation has announced the introduction of its advanced automated insulin delivery system in the Middle East, marking a strategic expansion if its global footprint and reinforcing its commitment to advancing diabetes care through innovative technologies.\n\nThe new systems combine continuous glucose monitoring with insulin delivery controlled by algorithms to allow for real-time adjustment of the insulin delivery depending on the dynamic changes in glucose. This smart automation will go a long way in minimizing the necessary human factor and increasing the levels of glycaemic control with the reduction of hyperglycaemia threats. The design of the system focuses on ease of use, portability, and comfort of patients to enhance compliance with treatment regimes.\n\nAccording to Precedence research, the artificial pancreas device system market was estimated at USD 410.20 million in 2025 and is predicted to increase from USD 480.75 million in 2026 to approximately USD 2,005.73 million by 2035, expanding at a CAGR of 17.20% from 2026 to 2035. The artificial pancreas device system market is a paradigm shift in the treatment of diabetes and combines the continuous glucose levels with automated insulin injection into the body to replicate the pancreatic...",
    "summary": "Insulet Corporation expands offices to Middle, New Jersey, United States, Northern America, Americas.",
    "category": "expands_offices_to",
    "found_at": "2026-03-25T00:00:00Z",
    "location": "Middle, New Jersey, United States, Northern America, Americas",
    "planning": false,
    "image_url": "https://www.precedenceresearch.com/insightimg/insulet.webp",
    "confidence": 0.6753,
    "published_at": "2026-03-25T00:00:00Z",
    "location_data": [
      {
        "city": "Middle",
        "state": "New Jersey",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Insulet Corporation has announced the introduction of its advanced automated insulin delivery system in the Middle East, marking a strategic expansion if its global footprint and reinforcing its commitment to advancing diabetes care through innovative technologies."
  }
}

curl https://signals.autobound.ai/v1/signals/b51f2a22-d585-4ce8-8b35-6fab70c77070 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"insulet.com","limit":20}'